Skip to search formSkip to main contentSkip to account menu

clevidipine

Known as: butyroxymethyl methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 
National Institutes of Health

Related topics

Related topics

7 relations
100 ML clevidipine 0.5 MG/ML Injection [Cleviprex]Calcium Channel Antagonists [MoA]Dihydropyridines

Broader (2)

Calcium Channel BlockersPyridines

Narrower (2)

Clevidipine butyrateCleviprex

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Clevidipine for Perioperative Blood Pressure Control in Infants and Children
Various pharmacologic agents have been used for perioperative BP control in pediatric patients, including sodium nitroprusside… 
Review
2011
Review
2011
Clevidipine for perioperative blood pressure control in infants and children undergoing cardiac surgery for congenital heart disease.
OBJECTIVE To determine the efficacy and adverse effect profile of clevidipine when used for perioperative blood pressure (BP… 
Review
2011
Review
2011
Clevidipine for Controlled Hypotension During Spinal Surgery in Adolescents
Background Clevidipine is an ultrashort-acting, intravenous calcium channel antagonist. Metabolism by blood and tissue esterases… 
Review
2010
Review
2010
Preliminary Experience With Clevidipine in the Pediatric Population
Clevidipine is a third-generation calcium channel antagonist of the dihydropyridine group. Like nicardipine, its primary… 
2009
2009
Clevidipine controls intraoperative blood pressure in an adolescent with renal failure.
In pediatric-aged patients, various factors may result in perioperative hypertension including renal failure or insufficiency… 
2007
2007
Initial volume of a drug before it reaches the volume of distribution: pharmacokinetics of F(ab')2 antivenoms and other drugs.
2007
2007
Diagnosis and treatment of hypertensive crises in the elderly patients
Hypertension is a common clinical problem in the elderly worldwide and physicians of all types are likely to encounter patients… 
Review
2007
Review
2007
New therapeutic perspectives with clevidipine: an ultra-short-acting intravenous Ca2+ channel blocker
Intravenous antihypertensive agents are used in clinical situations in which the immediate, precise control of blood pressure is… 
2004
2004
Failure to Demonstrate Myocardial Protective Effects of the Ultra Short-Acting Calcium Antagonist Clevidipine in a Closed-Chest Reperfusion Porcine Model
Restoration of myocardial perfusion is essential in acute myocardial infarction for the salvaging of myocardial tissue. However… 
1999
1999
Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans.
The pharmacokinetics of clevidipine, a potent short-acting vascular-selective calcium antagonist, was investigated during steady… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)